---
{"dg-publish":true,"permalink":"/research-summary/glycated-gd-59/"}
---


<script data-goatcounter="https://endocrinologyindia.goatcounter.com/count" async src="//gc.zgo.at/count.js"></script>

> [!note|+green]+ Created/Updated: #jan2025 


# Glycated CD59

**Summary of the Medical Article**

**1. Title of the Article**  

Glycated CD59 is a Potential Biomarker for Gestational Diabetes Mellitus.

**2. First Two Authors Followed by et al**  

Wanying Wang, Chong Xu et al.

**3. One-Line Summary of the Article**  

This study identifies glycated CD59 (gCD59) as an effective biomarker for diagnosing gestational diabetes mellitus (GDM), with enhanced accuracy when combined with fasting glucose levels.

**4. Six Key Points from the Article**  

1. **Elevated gCD59 Levels:** gCD59 levels were significantly higher in the GDM group (1.49 SPU) compared to the normal glucose tolerance (NGT) group (0.87 SPU).  
    
2. **Independent Risk Factor:** Multivariate analysis identified gCD59, diastolic blood pressure (DBP), and thyroid-stimulating hormone (TSH) as independent risk factors for GDM.  
    
3. **Diagnostic Performance:** The area under the curve (AUC) for gCD59 in diagnosing GDM was 0.681, with a sensitivity of 71.7% and specificity of 58.3%.  
    
4. **Combination with Fasting Glucose:** Combining gCD59 with fasting glucose improved diagnostic performance (AUC of 0.871).  
    
5. **Subgroup Analysis:** gCD59 demonstrated better diagnostic accuracy in normal and overweight BMI categories compared to obese categories.  
    
6. **Study Scope:** The study was conducted on a Chinese population, emphasizing the need for larger, multicenter studies for validation.
    

**5. Practical Take-Home Message**  

gCD59 shows promise as a biomarker for early and accurate diagnosis of GDM, especially when combined with fasting glucose levels, potentially reducing reliance on cumbersome tests like OGTT.

**6. Citation for the Article in Vancouver Format**  

Wang W, Xu C, Lu X, Cao W, Zuo T, Zhang Y, Zou H, Sun Y. Glycated CD59 is a potential biomarker for gestational diabetes mellitus. Front Endocrinol. 2024;15:1374253. doi: 10.3389/fendo.2024.1374253.